[Pregnancy and immunomodulatory therapy in multiple sclerosis patients].
Pregnancy and family planning issues are prominent concerns in the medical care of multiple sclerosis patients, since the disease onset often coincides with a period of life that is decisive in this regard. Multiple sclerosis is a chronic disorder with an unpredictable course and is widely treated with long-term immunomodulatory agents, raising questions regarding the complications and effects of these therapies on pregnancy. This paper gives an overview of the relevant literature and provides a basis for individual counselling of this group of multiple sclerosis patients.
Hoffmann
L A
LA
Institut für Klinische Neuroimmunologie, Klinikum der Universität München-Grosshadern, München. lisaann.hoffmann@med.uni-muenchen.de
Kümpfel
T
T
Heer
I
I
Hohlfeld
R
R
D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects* / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000150:complications* / Q000188:drug therapy*; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians'; D011247:Pregnancy; D011248:Pregnancy Complications / Q000139:chemically induced* / Q000517:prevention & control*
D007155:Immunologic Factors